LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article: Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

    Garmendia, Junkal / Frankel, Gad / Crepin, Valérie F

    Infection and immunity

    2005  Volume 73, Issue 5, Page(s) 2573–2585

    MeSH term(s) Animals ; Diarrhea/microbiology ; Diarrhea/physiopathology ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Escherichia coli/pathogenicity ; Escherichia coli Infections/microbiology ; Escherichia coli Infections/physiopathology ; Escherichia coli O157/genetics ; Escherichia coli O157/metabolism ; Escherichia coli O157/pathogenicity ; Escherichia coli Proteins/genetics ; Escherichia coli Proteins/metabolism ; Humans ; Intestines/microbiology ; Intestines/pathology ; Mice ; Protein Transport
    Chemical Substances Escherichia coli Proteins
    Language English
    Publishing date 2005-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 218698-6
    ISSN 1098-5522 ; 0019-9567
    ISSN (online) 1098-5522
    ISSN 0019-9567
    DOI 10.1128/IAI.73.5.2573-2585.2005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation

    Garmendia, Junkal / Frankel, Gad / Crepin, Valérie F

    Infection and immunity. 2005 May., v. 73, no. 5

    2005  

    Language English
    Dates of publication 2005-05
    Size p. 2573-2585.
    Document type Article
    ZDB-ID 218698-6
    ISSN 1098-5522 ; 0019-9567
    ISSN (online) 1098-5522
    ISSN 0019-9567
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.

    Mühlen, Sabrina / Zapol'skii, Viktor A / Bilitewski, Ursula / Dersch, Petra

    Antimicrobial agents and chemotherapy

    2021  Volume 65, Issue 12, Page(s) e0095821

    Abstract: Infections with enteropathogenic Escherichia coli (EPEC) cause severe diarrhea in children ... enterohemorrhagic E. coli infections. ... libraries and identified three substances which showed a significant dose-dependent effect on translocation ...

    Abstract Infections with enteropathogenic Escherichia coli (EPEC) cause severe diarrhea in children. The noninvasive bacteria adhere to enterocytes of the small intestine and use a type III secretion system (T3SS) to inject effector proteins into host cells to modify and exploit cellular processes in favor of bacterial survival and replication. Several studies have shown that the T3SSs of bacterial pathogens are essential for virulence. Furthermore, the loss of T3SS-mediated effector translocation results in increased immune recognition and clearance of the bacteria. The T3SS is, therefore, considered a promising target for antivirulence strategies and novel therapeutics development. Here, we report the results of a high-throughput screening assay based on the translocation of the EPEC effector protein Tir (translocated intimin receptor). Using this assay, we screened more than 13,000 small molecular compounds of six different compound libraries and identified three substances which showed a significant dose-dependent effect on translocation without adverse effects on bacterial or eukaryotic cell viability. In addition, these substances reduced bacterial binding to host cells, effector-dependent cell detachment, and abolished attaching and effacing lesion formation without affecting the expression of components of the T3SS or associated effector proteins. Moreover, no effects of the inhibitors on bacterial motility or Shiga-toxin expression were observed. In summary, we have identified three new compounds that strongly inhibit T3SS-mediated translocation of effectors into mammalian cells, which could be valuable as lead substances for treating EPEC and enterohemorrhagic E. coli infections.
    MeSH term(s) Animals ; Enteropathogenic Escherichia coli ; Escherichia coli Infections/drug therapy ; Escherichia coli Proteins/genetics ; HeLa Cells ; Humans ; Type III Secretion Systems/genetics ; Virulence
    Chemical Substances Escherichia coli Proteins ; Type III Secretion Systems
    Language English
    Publishing date 2021-09-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/AAC.00958-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Effects of Psidium guajava leaf extract on secretion systems of Gram-negative enteropathogenic bacteria.

    Nakasone, Noboru / Ogura, Yasunori / Higa, Naomi / Toma, Claudia / Koizumi, Yukiko / Takaesu, Giichi / Suzuki, Toshihiko / Yamashiro, Tetsu

    Microbiology and immunology

    2018  

    Abstract: ... the function of the type III secretion system (T3SS) of enteropathogenic Escherichia coli (EPEC) and ... treatment and prevention of gram-negative enteropathogenic bacterial infections. ... enterohemorrhagic E. coli (EHEC). Among candidates examined, we found that an extract from the leaves ...

    Abstract We screened a total of 672 plant-tissue extracts to search for phytochemicals that inhibit the function of the type III secretion system (T3SS) of enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC). Among candidates examined, we found that an extract from the leaves of Psidium guajava (guava) inhibited the secretion of the EspB protein from EPEC and EHEC without affecting bacterial growth. The guava extract (GE) also inhibited EPEC and EHEC from adhering to and injecting EspB protein into HEp-2 cells. GE seemed to block the translocation of EspB from the bacterial cells to the culture medium. In addition to EPEC and EHEC, GE also inhibited the T3SS of Yersinia pseudotuberculosis and Salmonella enterica serovar Typhimurium. After exposure to GE, Y. pseudotuberculosis stopped the secretion of Yop proteins and lost its ability to induce the apoptosis of mouse bone marrow-derived macrophages. S. Typhimurium exposed to GE ceased the secretion of Sip proteins and lost its ability to invade HEp-2 cells. GE inhibited EspC secretion, the type V secretion protein of EPEC, but not Shiga toxin2 from EHEC. Thus, our results suggest that guava leaves contain a novel type of antimicrobial compound that could be used for the therapeutic treatment and prevention of gram-negative enteropathogenic bacterial infections.
    Language English
    Publishing date 2018-05-23
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 224792-6
    ISSN 1348-0421 ; 0385-5600
    ISSN (online) 1348-0421
    ISSN 0385-5600
    DOI 10.1111/1348-0421.12604
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli.

    Mills, Erez / Baruch, Kobi / Aviv, Gili / Nitzan, Mor / Rosenshine, Ilan

    mBio

    2013  Volume 4, Issue 4

    Abstract: ... enterohemorrhagic Escherichia coli (EHEC) represent a global public health problem. New strategies to combat EPEC and EHEC infections ... based translocation assay, focusing mainly on enteropathogenic Escherichia coli (EPEC) and partly ... of the translocating bacteria, translocation temporal order, and relative amounts of each of the translocated effectors ...

    Abstract Unlabelled: Type III secretion systems (TTSSs) are employed by pathogens to translocate host cells with effector proteins, which are crucial for virulence. The dynamics of effector translocation, behavior of the translocating bacteria, translocation temporal order, and relative amounts of each of the translocated effectors are all poorly characterized. To address these issues, we developed a microscopy-based assay that tracks effector translocation. We used this assay alongside a previously described real-time population-based translocation assay, focusing mainly on enteropathogenic Escherichia coli (EPEC) and partly comparing it to Salmonella. We found that the two pathogens exhibit different translocation behaviors: in EPEC, a subpopulation that formed microcolonies carried out most of the translocation activity, while Salmonella executed protein translocation as planktonic bacteria. We also noted variability in host cell susceptibility, with some cells highly resistant to translocation. We next extended the study to determine the translocation dynamics of twenty EPEC effectors and found that all exhibited distinct levels of translocation efficiency. Further, we mapped the global effects of key TTSS-related components on TTSS activity. Our results provide a comprehensive description of the dynamics of the TTSS activity of EPEC and new insights into the mechanisms that control the dynamics.
    Importance: EPEC and the closely related enterohemorrhagic Escherichia coli (EHEC) represent a global public health problem. New strategies to combat EPEC and EHEC infections are needed, and development of such strategies requires better understanding of their virulence machinery. The TTSS is a critical virulence mechanism employed by these pathogens, and by others, including Salmonella. In this study, we aimed at elucidating new aspects of TTSS function. The results obtained provide a comprehensive description of the dynamics of TTSS activity of EPEC and new insights into the mechanisms that control these changes. This knowledge sets the stage for further analysis of the system and may accelerate the development of new ways to treat EPEC and EHEC infections. Further, the newly described microscopy-based assay can be readily adapted to study the dynamics of TTSS activity in other pathogens.
    MeSH term(s) Bacterial Proteins/metabolism ; Bacterial Secretion Systems ; Enteropathogenic Escherichia coli/metabolism ; Epithelial Cells/microbiology ; HeLa Cells ; Humans ; Protein Transport ; Salmonella/metabolism ; Virulence Factors/metabolism
    Chemical Substances Bacterial Proteins ; Bacterial Secretion Systems ; Virulence Factors
    Language English
    Publishing date 2013-07-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.00303-13
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Dynamics of the Type III Secretion System Activity of Enteropathogenic Escherichia coli

    Mills, Erez / Baruch, Kobi / Aviv, Gili / Nitzan, Mor / Rosenshine, Ilan

    mBio. 2013 Aug. 30, v. 4, no. 4

    2013  

    Abstract: ... enterohemorrhagic Escherichia coli (EHEC) represent a global public health problem. New strategies to combat EPEC and EHEC infections ... based translocation assay, focusing mainly on enteropathogenic Escherichia coli (EPEC) and partly ... of the translocating bacteria, translocation temporal order, and relative amounts of each of the translocated effectors ...

    Abstract Type III secretion systems (TTSSs) are employed by pathogens to translocate host cells with effector proteins, which are crucial for virulence. The dynamics of effector translocation, behavior of the translocating bacteria, translocation temporal order, and relative amounts of each of the translocated effectors are all poorly characterized. To address these issues, we developed a microscopy-based assay that tracks effector translocation. We used this assay alongside a previously described real-time population-based translocation assay, focusing mainly on enteropathogenic Escherichia coli (EPEC) and partly comparing it to Salmonella . We found that the two pathogens exhibit different translocation behaviors: in EPEC, a subpopulation that formed microcolonies carried out most of the translocation activity, while Salmonella executed protein translocation as planktonic bacteria. We also noted variability in host cell susceptibility, with some cells highly resistant to translocation. We next extended the study to determine the translocation dynamics of twenty EPEC effectors and found that all exhibited distinct levels of translocation efficiency. Further, we mapped the global effects of key TTSS-related components on TTSS activity. Our results provide a comprehensive description of the dynamics of the TTSS activity of EPEC and new insights into the mechanisms that control the dynamics. IMPORTANCE EPEC and the closely related enterohemorrhagic Escherichia coli (EHEC) represent a global public health problem. New strategies to combat EPEC and EHEC infections are needed, and development of such strategies requires better understanding of their virulence machinery. The TTSS is a critical virulence mechanism employed by these pathogens, and by others, including Salmonella . In this study, we aimed at elucidating new aspects of TTSS function. The results obtained provide a comprehensive description of the dynamics of TTSS activity of EPEC and new insights into the mechanisms that control these changes. This knowledge sets the stage for further analysis of the system and may accelerate the development of new ways to treat EPEC and EHEC infections. Further, the newly described microscopy-based assay can be readily adapted to study the dynamics of TTSS activity in other pathogens.
    Keywords Salmonella ; bacteria ; enterohemorrhagic Escherichia coli ; enteropathogenic Escherichia coli ; pathogens ; protein transport ; public health ; type III secretion system ; virulence
    Language English
    Dates of publication 2013-0830
    Size p. e00303-13.
    Publishing place American Society for Microbiology
    Document type Article
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.00303-13
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha.

    Gareau, Mélanie G / Ho, Nathan K / Brenner, Dirk / Sousa, Andrew J / LeBourhis, Lionel / Mak, Tak W / Girardin, Stephen E / Philpott, Dana J / Sherman, Philip M

    Microbiology (Reading, England)

    2011  Volume 157, Issue Pt 10, Page(s) 2963–2973

    Abstract: Enterohaemorrhagic Escherichia coli (EHEC), serotype O157 : H7 is a non-invasive ... of IκBα), immunofluorescence (p65 nuclear translocation) and immunoassay (CXCL-8 secretion), and each was ... following exposure to either enteropathogenic E. coli, strain E2348/69 (O127 : H6) or the laboratory E. coli ...

    Abstract Enterohaemorrhagic Escherichia coli (EHEC), serotype O157 : H7 is a non-invasive, pathogenic bacterium that employs a type III secretion system (T3SS) to inject effector proteins into infected cells. In this study, we demonstrate that EHEC blocks tumour necrosis factor-alpha (TNFα)-induced NF-κB signalling in infected epithelial cells. HEK293T and INT407 epithelial cells were challenged with EHEC prior to stimulation with TNFα. Using complementary techniques, stimulation with TNFα caused activation of NF-κB, as determined by luciferase reporter assay (increase in gene expression), Western blotting (phosphorylation of IκBα), immunofluorescence (p65 nuclear translocation) and immunoassay (CXCL-8 secretion), and each was blocked by EHEC O157 : H7 infection. In contrast, subversion of host cell signalling was not observed following exposure to either enteropathogenic E. coli, strain E2348/69 (O127 : H6) or the laboratory E. coli strain HB101. Heat-killed EHEC had no effect on NF-κB activation by TNFα. Inhibition was mediated, at least in part, by Shiga toxins and by the O157 plasmid, but not by the T3SS or flagellin, as demonstrated by using isogenic mutant strains. These findings indicate the potential for developing novel therapeutic targets to interrupt the infectious process.
    MeSH term(s) Cell Line/microbiology ; Enterohemorrhagic Escherichia coli/genetics ; Enterohemorrhagic Escherichia coli/physiology ; Epithelial Cells/metabolism ; Epithelial Cells/microbiology ; Escherichia coli Infections/metabolism ; Escherichia coli Infections/microbiology ; Escherichia coli O157/genetics ; Escherichia coli O157/physiology ; Humans ; NF-kappa B/metabolism ; Signal Transduction ; Tumor Necrosis Factor-alpha/metabolism
    Chemical Substances NF-kappa B ; Tumor Necrosis Factor-alpha
    Language English
    Publishing date 2011-07-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180712-x
    ISSN 1465-2080 ; 1350-0872
    ISSN (online) 1465-2080
    ISSN 1350-0872
    DOI 10.1099/mic.0.051094-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.

    Arbeloa, Ana / Oates, Clare V / Marchès, Oliver / Hartland, Elizabeth L / Frankel, Gad

    Infection and immunity

    2010  Volume 79, Issue 3, Page(s) 1067–1076

    Abstract: Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli (EHEC) are ... for subversion of signal transduction pathways and colonization of the mammalian gut mucosa. While a core set ... of effectors is conserved between EPEC and EHEC strains, a growing number of accessory effectors that were ...

    Abstract Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic Escherichia coli (EHEC) are important human pathogens that rely on translocation of type III secretion system (T3SS) effectors for subversion of signal transduction pathways and colonization of the mammalian gut mucosa. While a core set of effectors is conserved between EPEC and EHEC strains, a growing number of accessory effectors that were found at various frequencies in clinical and environmental isolates have been recently identified. Recent genome projects identified espV as a pseudogene in EHEC but a putative functional gene in EPEC strains E110019 and E22 and the closely related mouse pathogen Citrobacter rodentium. The aim of this study was to determine the distribution of espV among clinical EPEC and EHEC strains and to investigate its function and role in pathogenesis. espV was found in 16% of the tested strains. While deletion of espV from C. rodentium did not affect colonization dynamics or fitness in mixed infections, expression of EspV in mammalian cells led to drastic morphological alterations, which were characterized by nuclear condensation, cell rounding, and formation of dendrite-like projections. Expression of EspV in yeast resulted in a dramatic increase in cell size and irreversible growth arrest. Although the role of EspV in infection and its target host cell protein(s) require further investigation, the data point to a novel mechanism by which the T3SS subverts cell signaling.
    MeSH term(s) Amino Acid Sequence ; Animals ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Bacterial Secretion Systems/genetics ; Citrobacter rodentium/metabolism ; Enterohemorrhagic Escherichia coli/genetics ; Enterohemorrhagic Escherichia coli/metabolism ; Enterohemorrhagic Escherichia coli/pathogenicity ; Enteropathogenic Escherichia coli/genetics ; Enteropathogenic Escherichia coli/metabolism ; Enteropathogenic Escherichia coli/pathogenicity ; Escherichia coli Infections/genetics ; Escherichia coli Infections/metabolism ; Eukaryotic Cells/microbiology ; Fluorescent Antibody Technique ; Genes, Bacterial/genetics ; HeLa Cells ; Humans ; Mice ; Microscopy, Electron, Scanning ; Molecular Sequence Data ; Virulence
    Chemical Substances Bacterial Proteins ; Bacterial Secretion Systems
    Language English
    Publishing date 2010-12-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218698-6
    ISSN 1098-5522 ; 0019-9567
    ISSN (online) 1098-5522
    ISSN 0019-9567
    DOI 10.1128/IAI.01003-10
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli.

    Larzábal, Mariano / Mercado, Elsa C / Vilte, Daniel A / Salazar-González, Hector / Cataldi, Angel / Navarro-Garcia, Fernando

    PloS one

    2010  Volume 5, Issue 2, Page(s) e9046

    Abstract: Background: Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are two ... pedestals by the same strain in HEp-2 cells and impaired the TTSS-mediated protein translocation ... causing a characteristic attaching and effacing lesion (A/E). The TTSS translocates effector proteins ...

    Abstract Background: Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are two categories of E. coli strains associated with human disease. A major virulence factor of both pathotypes is the expression of a type three secretion system (TTSS), responsible for their ability to adhere to gut mucosa causing a characteristic attaching and effacing lesion (A/E). The TTSS translocates effector proteins directly into the host cell that subvert mammalian cell biochemistry.
    Methods/principal findings: We examined synthetic peptides designed to inhibit the TTSS. CoilA and CoilB peptides, both representing coiled-coil regions of the translocator protein EspA, and CoilD peptide, corresponding to a coiled-coil region of the needle protein EscF, were effective in inhibiting the TTSS dependent hemolysis of red blood cells by the EPEC E2348/69 strain. CoilA and CoilB peptides also reduced the formation of actin pedestals by the same strain in HEp-2 cells and impaired the TTSS-mediated protein translocation into the epithelial cell. Interestingly, CoilA and CoilB were able to block EspA assembly, destabilizing the TTSS and thereby Tir translocation. This blockage of EspA polymerization by CoilA or CoilB peptides, also inhibited the correct delivery of EspB and EspD as detected by immunoblotting. Interestingly, electron microscopy of bacteria incubated with the CoilA peptide showed a reduction of the length of EspA filaments.
    Conclusions: Our data indicate that coiled-coil peptides can prevent the assembly and thus the functionality of the TTSS apparatus and suggest that these peptides could provide an attractive tool to block EPEC and EHEC pathogenesis.
    MeSH term(s) Amino Acid Sequence ; Animals ; Bacterial Outer Membrane Proteins/metabolism ; Blotting, Western ; Cell Line, Tumor ; Cytoskeletal Proteins/chemistry ; Cytoskeletal Proteins/metabolism ; Enteropathogenic Escherichia coli/drug effects ; Enteropathogenic Escherichia coli/metabolism ; Erythrocytes/drug effects ; Erythrocytes/microbiology ; Escherichia coli Infections/microbiology ; Escherichia coli Proteins/chemistry ; Escherichia coli Proteins/metabolism ; Escherichia coli Proteins/ultrastructure ; Hemolysis/drug effects ; Humans ; Microbial Viability/drug effects ; Microscopy, Immunoelectron ; Molecular Sequence Data ; Peptides/chemical synthesis ; Peptides/pharmacology ; Protein Transport/drug effects ; Sheep
    Chemical Substances Bacterial Outer Membrane Proteins ; Cytoskeletal Proteins ; EaeB protein, E coli ; EscF protein, E coli ; Escherichia coli Proteins ; EspA protein, E coli ; EspD protein, E coli ; Peptides
    Language English
    Publishing date 2010-02-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0009046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Distribution of tccP in clinical enterohemorrhagic and enteropathogenic Escherichia coli isolates.

    Garmendia, Junkal / Ren, Zhihong / Tennant, Sharon / Midolli Viera, Monica Aparecida / Chong, Yuwen / Whale, Andrew / Azzopardi, Kristy / Dahan, Sivan / Sircili, Marcelo Palma / Franzolin, Marcia Regina / Trabulsi, Luiz R / Phillips, Alan / Gomes, Tânia A T / Xu, Jianguo / Robins-Browne, Roy / Frankel, Gad

    Journal of clinical microbiology

    2005  Volume 43, Issue 11, Page(s) 5715–5720

    Abstract: Enterohemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC) are diarrheagenic ... pathogens that colonize the gut through the formation of attaching and effacing lesions, which depend ... Recently, two effector proteins, EspJ and TccP, which are encoded by adjacent genes on prophage CP-933U ...

    Abstract Enterohemorrhagic Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC) are diarrheagenic pathogens that colonize the gut through the formation of attaching and effacing lesions, which depend on the translocation of effector proteins via a locus of enterocyte effacement-encoded type III secretion system. Recently, two effector proteins, EspJ and TccP, which are encoded by adjacent genes on prophage CP-933U in EHEC O157:H7, have been identified. TccP consists of a unique N-terminus region and several proline-rich domains. In this project we determined the distribution of tccP in O157:H7, in non-O157 EHEC, and in typical and atypical EPEC isolates. All the EHEC O157:H7 strains tested were tccP(+). Unexpectedly, tccP was also found in non-O157 EHEC, and in typical and atypical EPEC isolates, particularly in strains belonging to serogroups O26 (EHEC), O119 (typical EPEC), and O55 (atypical EPEC). We recorded some variation in the length of tccP, which reflects diversity in the number of the proline-rich repeats. These results show the existence of a class of "attaching and effacing" pathogens which express a combination of EPEC and EHEC virulence determinants.
    MeSH term(s) Animals ; Australia ; Brazil ; China ; Escherichia coli/chemistry ; Escherichia coli/genetics ; Escherichia coli Infections/microbiology ; Escherichia coli Infections/veterinary ; Escherichia coli O157/chemistry ; Escherichia coli O157/genetics ; Escherichia coli Proteins/genetics ; Food Microbiology ; Genetic Variation ; Humans ; Molecular Sequence Data ; United Kingdom
    Chemical Substances Escherichia coli Proteins ; EspJ protein, E coli ; tccP protein, E coli
    Language English
    Publishing date 2005-09-29
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/JCM.43.11.5715-5720.2005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top